$OTLK

$0.64▲ +3.2% YTD

4 SEC 13D/G filings tracked · Last updated Aug 27, 2026

Filing History

OTLK ▲ +3.2% - Outlook Therapeutics, Inc.

CP $0.64▲ +3.2%Aug 27, 2026 · ThinkSabio Blog

$OTLK OTLKW - Outlook Therapeutics Appoints Kevin Lundquist as Chief Financial Officer as It Prepares for U.S. Commercial Launch of LYTENAVA™…

News

OTLK ▲ +1.6% - Outlook Therapeutics, Inc.

CP 0.63▲ +1.6%Aug 27, 2026 · ThinkSabio Blog

$OTLK OTLKW - Outlook Therapeutics CEO, Bob Jahr, Participates in the Virtual Investor “Why Now” On-Demand Conference…

SEC 13D/G

OTLK - Outlook Therapeutics, Inc. - SEC Filing Update (19-AUG-2026) | ThinkSabio - Stocks Simplified

$0.70▲ 6.06%Aug 19, 2026 · ThinkSabio Blog

$OTLK SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #OTLK Outlook Therapeutics, Inc. : $0.70 Sector: Healthcare | YT…

SEC 13D/G

OTLK - Outlook Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified

$0.79▲ 19.70%Aug 15, 2026 · ThinkSabio Blog

$OTLK SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #OTLK Outlook Therapeutics, Inc. : $0.79 Sector: Healthcare | YT…